OMNI PARTNERS LLP has disclosed 169 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2021-03-31. The current portfolio value is calculated to be $1.86 Bil. The turnover rate is 53%.
In OMNI PARTNERS LLP's current portfolio as of 2021-03-31, the top 5 holdings are
RealPage Inc (RP), Alexion Pharmaceuticals Inc (ALXN), Slack Technologies Inc (WORK), Xilinx Inc (XLNX), GW Pharmaceuticals PLC (GWPH), not including call and put options.
OMNI PARTNERS LLP did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for OMNI PARTNERS LLP, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for OMNI PARTNERS LLP, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for OMNI PARTNERS LLP.